ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,435Medicare Part D Prescriptions Filled, Including Refills

Rank: 351 out of 1844

$495K Total Retail Price of All Prescriptions

Rank: 364 out of 1844

395 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

11% of this provider’s 395 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 7,379 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
LEVOTHYROXINE SODIUM 429 408 1 1
SIMVASTATIN 347 336 2 3
ATENOLOL 320 270 3 17
OMEPRAZOLE 274 230 4 5
FUROSEMIDE 218 191 5 7
ATORVASTATIN CALCIUM 192 179 6 12
TRAMADOL HCL 181 175 7 18
HYDROCODONE-ACETAMINOPHEN 178 134 S3 8 2
AMLODIPINE BESYLATE 173 165 9 6
METFORMIN HCL 172 133 10 8
ENALAPRIL MALEATE 171 163 11 69
ZOLPIDEM TARTRATE 150 129 12 23
CARVEDILOL 149 130 13 22
CLOPIDOGREL 146 138 14 34
LOSARTAN POTASSIUM 139 139 15 24
PLAVIX 120 116 16 61
ALLOPURINOL 117 113 17 29
DONEPEZIL HCL 115 115 18 26
CITALOPRAM HBR 114 109 19 19
METOPROLOL TARTRATE 104 104 20 11
POTASSIUM CHLORIDE 103 87 21 16
CYMBALTA 97 60 22 36
ISOSORBIDE MONONITRATE ER 97 88 22 59
LEVOFLOXACIN 93 86 24 78
POLYETHYLENE GLYCOL 3350 93 64 24 39
MELOXICAM 92 89 26 28
TRIAMTERENE-HCTZ 92 84 26 48
GLYBURIDE 91 77 R 28 100
SYNTHROID 88 87 29 55
SERTRALINE HCL 85 75 30 21
PANTOPRAZOLE SODIUM 85 79 30 32
WARFARIN SODIUM 81 76 32 13
GABAPENTIN 79 69 33 15
LISINOPRIL 76 70 34 4
MECLIZINE HCL 75 67 35 142
AMITRIPTYLINE HCL 73 62 R 36 72
NEXIUM 73 61 36 31
CLOTRIMAZOLE-BETAMETHASONE 72 67 38 202
METOPROLOL SUCCINATE 69 68 39 14
INSULIN SYRINGE 68 44 40 111
GEMFIBROZIL 61 54 41 108
CIPROFLOXACIN HCL 58 54 42 62
LEVEMIR 56 43 43 157
LANTUS 54 54 44 42
BUSPIRONE HCL 50 31 45 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.